201
|
Tylzanowski P, De Valck D, Maes V, Peeters J, Luyten FP. Zfhx1a and Zfhx1b mRNAs have non-overlapping expression domains during chick and mouse midgestation limb development. Gene Expr Patterns 2003; 3:39-42. [PMID: 12609600 DOI: 10.1016/s1567-133x(02)00092-3] [Citation(s) in RCA: 15] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
Smad-interacting protein 1 (Zfhx1b, Sip1) and Zfhx1a (deltaEF1) are transcriptional repressors belonging to the family of two-handed zinc finger/homeodomain proteins. Both of the proteins bind to a bipartite CACCT/CACCTG DNA sequence, but only Sip 1 can interact with activated SMAD proteins in vitro. To gain insight into their developmental roles, we investigated the mRNA expression patterns of both genes in developing mouse and chick limbs by in situ hybridization. To improve the resolution of the expression mapping we have used a dual in situ hybridization (DISH) technique allowing for a detection of expression of two different mRNAs on the same tissue section. Using DISH we could demonstrate that both genes were expressed in distinct non-overlapping patterns in developing limbs of both species. Zfhx1a was expressed in a cell population immediately adjacent to cartilage anlagen as well as in developing tendons. Zfhx1b, in contrast, was present in a broad area around developing tendon and partially overlapping with the expression of genes associated with myogenic differentiation.
Collapse
Affiliation(s)
- Przemko Tylzanowski
- Laboratory of Skeletal Development and Joint Disorders, University of Leuven, Herestraat 49, 3000 Leuven, Belgium [corrected].
| | | | | | | | | |
Collapse
|
202
|
McCallion AS, Stames E, Conlon RA, Chakravarti A. Phenotype variation in two-locus mouse models of Hirschsprung disease: tissue-specific interaction between Ret and Ednrb. Proc Natl Acad Sci U S A 2003; 100:1826-31. [PMID: 12574515 PMCID: PMC149918 DOI: 10.1073/pnas.0337540100] [Citation(s) in RCA: 119] [Impact Index Per Article: 5.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/07/2023] Open
Abstract
Clinical expression of Hirschsprung disease (HSCR) requires the interaction of multiple susceptibility genes. Molecular genetic analyses have revealed that interactions between mutations in the genes encoding the RET receptor tyrosine kinase and the endothelin receptor type B (EDNRB) are central to the genesis of HSCR. We have established two locus noncomplementation assays in mice, using allelic series at Ednrb in the context of Ret kinase-null heterozygotes, to understand the clinical presentation, incomplete penetrance, variation in length of aganglionic segment, and sex bias observed in human HSCR patients. Titration of Ednrb in the presence of half the genetic dose of Ret determines the presentation of an enteric phenotype in these strains, revealing or abrogating a sex bias in disease expression depending on the genotype at Ednrb. RET and EDNRB signaling pathways are also critical for the normal development of other tissues, including the kidneys and neural crest-derived melanocytes. Our data demonstrate that interaction between these genes is restricted to the enteric nervous system and does not affect renal, coat color, and retinal choroid development.
Collapse
Affiliation(s)
- Andrew S McCallion
- McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA
| | | | | | | |
Collapse
|
203
|
Battaglia A, Carey JC. Diagnostic evaluation of developmental delay/mental retardation: An overview. AMERICAN JOURNAL OF MEDICAL GENETICS. PART C, SEMINARS IN MEDICAL GENETICS 2003; 117C:3-14. [PMID: 12561053 DOI: 10.1002/ajmg.c.10015] [Citation(s) in RCA: 90] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/08/2022]
Abstract
Mental retardation (MR) is one of the few clinically important disorders for which the etiopathogenesis is still poorly understood. It is a condition of great concern for public health and society. MR is currently defined as a significant impairment of cognitive and adaptive functions, with onset before age 18 years. It may become evident during infancy or early childhood as developmental delay (DD), but it is best diagnosed during the school years. MR is estimated to occur in 1-10% of the population, and research on its etiology has always been a challenge in medicine. The etiopathogenesis encompasses so many different entities that the attending physician can sometimes feel a "virtual panic," starting a wide-range diagnostic evaluation. The Consensus Conference of the American College of Medical Genetics has recently established guidelines regarding the evaluation of patients with MR [Curry et al., 1997], emphasizing the high diagnostic utility of cytogenetic studies and neuroimaging in certain clinical settings. However, since then there has been substantial progress in molecular cytogenetics and neuroimaging techniques, the use of which has allowed recognition and definition of new disorders, thus increasing the diagnostic yield. This review will focus on the most appropriate investigations shown to be, at present, necessary to define the etiology of DD/MR, in the context of recommendations for the clinical evaluation of the patient with undiagnosed MR.
Collapse
Affiliation(s)
- Agatino Battaglia
- Division of Pediatric Neurology and Psychiatry, Department of Procreative Medicine and Pediatrics, University of Pisa, Pisa, Italy.
| | | |
Collapse
|
204
|
Garavelli L, Donadio A, Zanacca C, Banchini G, Della Giustina E, Bertani G, Albertini G, Del Rossi C, Zweier C, Rauch A, Zollino M, Neri G. Hirschsprung disease, mental retardation, characteristic facial features, and mutation in the gene ZFHX1B (SIP1): confirmation of the Mowat-Wilson syndrome. Am J Med Genet A 2003; 116A:385-8. [PMID: 12522797 DOI: 10.1002/ajmg.a.10855] [Citation(s) in RCA: 48] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
|
205
|
Van de Putte T, Maruhashi M, Francis A, Nelles L, Kondoh H, Huylebroeck D, Higashi Y. Mice lacking ZFHX1B, the gene that codes for Smad-interacting protein-1, reveal a role for multiple neural crest cell defects in the etiology of Hirschsprung disease-mental retardation syndrome. Am J Hum Genet 2003; 72:465-70. [PMID: 12522767 PMCID: PMC379238 DOI: 10.1086/346092] [Citation(s) in RCA: 217] [Impact Index Per Article: 10.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/22/2002] [Accepted: 10/29/2002] [Indexed: 12/21/2022] Open
Abstract
Recently, mutations in ZFHX1B, the gene that encodes Smad-interacting protein-1 (SIP1), were found to be implicated in the etiology of a dominant form of Hirschsprung disease-mental retardation syndrome in humans. To clarify the molecular mechanisms underlying the clinical features of SIP1 deficiency, we generated mice that bear a mutation comparable to those found in several human patients. Here, we show that Zfhx1b-knockout mice do not develop postotic vagal neural crest cells, the precursors of the enteric nervous system that is affected in patients with Hirschsprung disease, and they display a delamination arrest of cranial neural crest cells, which form the skeletomuscular elements of the vertebrate head. This suggests that Sip1 is essential for the development of vagal neural crest precursors and the migratory behavior of cranial neural crest in the mouse. Furthermore, we show that Sip1 is involved in the specification of neuroepithelium.
Collapse
Affiliation(s)
- Tom Van de Putte
- Department of Developmental Biology, Flanders Interuniversity Institute for Biotechnology, and Laboratory of Molecular Biology (Celgen), University of Leuven, Leuven, Belgium; Laboratory of Developmental Biology, Graduate School of Frontier Bioscience, Osaka University, Osaka, Japan
| | - Mitsuji Maruhashi
- Department of Developmental Biology, Flanders Interuniversity Institute for Biotechnology, and Laboratory of Molecular Biology (Celgen), University of Leuven, Leuven, Belgium; Laboratory of Developmental Biology, Graduate School of Frontier Bioscience, Osaka University, Osaka, Japan
| | - Annick Francis
- Department of Developmental Biology, Flanders Interuniversity Institute for Biotechnology, and Laboratory of Molecular Biology (Celgen), University of Leuven, Leuven, Belgium; Laboratory of Developmental Biology, Graduate School of Frontier Bioscience, Osaka University, Osaka, Japan
| | - Luc Nelles
- Department of Developmental Biology, Flanders Interuniversity Institute for Biotechnology, and Laboratory of Molecular Biology (Celgen), University of Leuven, Leuven, Belgium; Laboratory of Developmental Biology, Graduate School of Frontier Bioscience, Osaka University, Osaka, Japan
| | - Hisato Kondoh
- Department of Developmental Biology, Flanders Interuniversity Institute for Biotechnology, and Laboratory of Molecular Biology (Celgen), University of Leuven, Leuven, Belgium; Laboratory of Developmental Biology, Graduate School of Frontier Bioscience, Osaka University, Osaka, Japan
| | - Danny Huylebroeck
- Department of Developmental Biology, Flanders Interuniversity Institute for Biotechnology, and Laboratory of Molecular Biology (Celgen), University of Leuven, Leuven, Belgium; Laboratory of Developmental Biology, Graduate School of Frontier Bioscience, Osaka University, Osaka, Japan
| | - Yujiro Higashi
- Department of Developmental Biology, Flanders Interuniversity Institute for Biotechnology, and Laboratory of Molecular Biology (Celgen), University of Leuven, Leuven, Belgium; Laboratory of Developmental Biology, Graduate School of Frontier Bioscience, Osaka University, Osaka, Japan
| |
Collapse
|
206
|
Borrego S, Wright FA, Fernández RM, Williams N, López-Alonso M, Davuluri R, Antiñolo G, Eng C. A founding locus within the RET proto-oncogene may account for a large proportion of apparently sporadic Hirschsprung disease and a subset of cases of sporadic medullary thyroid carcinoma. Am J Hum Genet 2003; 72:88-100. [PMID: 12474140 PMCID: PMC420016 DOI: 10.1086/345466] [Citation(s) in RCA: 78] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/25/2002] [Accepted: 10/07/2002] [Indexed: 12/28/2022] Open
Abstract
Hirschsprung disease (HSCR) is a common congenital disorder characterized by aganglionosis of the gut. The seemingly unrelated multiple endocrine neoplasia type 2 (MEN 2) is an autosomal dominant disorder characterized by medullary thyroid carcinoma (MTC), pheochromocytoma, and hyperparathyroidism. Yet, germline mutations in the RET proto-oncogene are associated with both MEN 2 and HSCR. In the former, gain-of-function mutations in a limited set of codons is found, whereas, in the latter, loss-of-function mutations are found. However, germline RET mutation is associated with only 3% of a population-based series of isolated HSCR, and little is known about susceptibility to sporadic MTC. We have found previously that specific haplotypes comprising RET coding single-nucleotide polymorphisms (SNPs) comprising exon 2 SNP A45A were strongly associated with HSCR, whereas haplotypes associated with exon 14 SNP S836S were associated with MTC. In this study, we describe three novel intron 1 SNPs, and, together with the coding SNP haplotypes, the data suggest the presence of distinct ancestral haplotypes for HSCR and sporadic MTC in linkage disequilibrium with a putative founding susceptibility locus/loci. The data are consistent with the presence of a very ancient, low-penetrance founder locus approximately 20-30 kb upstream of SNP A45A, but the failure of the SNPs to span the locus presents challenges in modeling mode of transmission or ancestry. We postulate that this founding locus is germane to both isolated HSCR and MTC but also that different mutations in this locus would predispose to one or the other.
Collapse
Affiliation(s)
- Salud Borrego
- Unidad de Genética Médica y Diagnóstico Prenatal, Hospitales Universitarios Virgen del Rocío, Sevilla, Spain.
| | | | | | | | | | | | | | | |
Collapse
|
207
|
Horn D, Weschke B, Zweier C, Rauch A. Facial phenotype allows diagnosis of Mowat-Wilson syndrome in the absence of hirschsprung disease. ACTA ACUST UNITED AC 2003; 124A:102-4. [PMID: 14679597 DOI: 10.1002/ajmg.a.20298] [Citation(s) in RCA: 25] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
|
208
|
de Santa Barbara P, van den Brink GR, Roberts DJ. Molecular etiology of gut malformations and diseases. AMERICAN JOURNAL OF MEDICAL GENETICS 2002; 115:221-30. [PMID: 12503117 DOI: 10.1002/ajmg.10978] [Citation(s) in RCA: 56] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/08/2023]
Abstract
This review describes recent advances using animal models in the analysis of the molecular controls of gastrointestinal development, with specific attention to mutations causing maldevelopment similar to those seen in human gut malformations. By focusing on specific human gut pathologic conditions and maldevelopment, we describe the probable roles of signaling pathways, including the hedgehog pathway, the bone morphogenic protein pathway, and the role of the homeotic genes.
Collapse
Affiliation(s)
- Pascal de Santa Barbara
- Department of Pathology, Harvard Medical School, Massachusetts General Hospital, Boston, MA 02114, USA
| | | | | |
Collapse
|
209
|
Abstract
Members of the TGF-beta superfamily, which includes TGF-betas, growth differentiation factors, bone morphogenetic proteins, activins, inhibins, and glial cell line-derived neurotrophic factor, are synthesized as prepropeptide precursors and then processed and secreted as homodimers or heterodimers. Most ligands of the family signal through transmembrane serine/threonine kinase receptors and SMAD proteins to regulate cellular functions. Many studies have reported the characterization of knockout and knock-in transgenic mice as well as humans or other mammals with naturally occurring genetic mutations in superfamily members or their regulatory proteins. These investigations have revealed that TGF-beta superfamily ligands, receptors, SMADs, and upstream and downstream regulators function in diverse developmental and physiological pathways. This review attempts to collate and integrate the extensive body of in vivo mammalian studies produced over the last decade.
Collapse
Affiliation(s)
- Hua Chang
- Department of Pathology, Baylor College of Medicine, One Baylor Plaza, Houston, Texas 77030, USA
| | | | | |
Collapse
|
210
|
Nagaya M, Kato J, Niimi N, Tanaka S, Wakamatsu N. Clinical features of a form of Hirschsprung's disease caused by a novel genetic abnormality. J Pediatr Surg 2002; 37:1117-22. [PMID: 12149685 DOI: 10.1053/jpsu.2002.34455] [Citation(s) in RCA: 19] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Abstract
BACKGROUND/PURPOSE The aim of this report is to describe the pattern of similarities among the patients, exemplifying a newly recognized form of Hirschsprung's disease (HSCR) caused by mutations of ZFHX1B encoding Smad interacting protein-1. METHODS Fluorescence in situ hybridization (FISH) using several cDNAs and RP11-BAC clones and mutation gene scanning using direct nucleotide sequencing analysis of polymerase chain reaction (PCR) were conducted. Personal records of the patients also were analyzed retrospectively to confirm the clinical features. RESULTS All the patients represented isolated cases without any familial tendency. Aganglionic segments were limited to the recto-sigmoid colon in 3 cases and the rectum in one. Chromosomal screening found normal karyotypes in all cases except one, in whom a translocation between chromosomes 2 and 13 was detected. In addition to HSCR, characteristic facial appearance (hypertelorism with strabismus and wide nasal bridge), microcephaly with epilepsy, and severe physical and mental disabilities were found in all the patients. FISH for the patient having the chromosomal abnormality showed that about a 5-Mb cytogenetic deletion flanked at the 2q22 translocation breakpoint. Among 3 genes mapping to this deleted region, 2 nonsense mutations and a 4-base pair deletion were detected in ZFHX1B. CONCLUSIONS The clinical features of the patients have surprising resemblance and constitute a wide spectrum of neurocristopathies. These findings suggest that the ZFHX1B may be a very important gene for normal embryonic neural crest development. These also indicate that the HSCR can be regarded as a congenital malformation with a background of a multigenetic neurocristopathy. It is of great interest that mutations were located at the same spot (exon 8) of ZFHX1B in 3 of 4 cases, probably accounting for the unique clinical features of this newly recognized form of HSCR.
Collapse
Affiliation(s)
- Masahiro Nagaya
- Department of Pediatric Surgery, the Central Hospital, Aichi Prefectural Colony, Kasugai, Japan
| | | | | | | | | |
Collapse
|
211
|
Espinosa-Parrilla Y, Amiel J, Augé J, Encha-Razavi F, Munnich A, Lyonnet S, Vekemans M, Attié-Bitach T. Expression of the SMADIP1 gene during early human development. Mech Dev 2002; 114:187-91. [PMID: 12175509 DOI: 10.1016/s0925-4773(02)00062-x] [Citation(s) in RCA: 32] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/31/2023]
Abstract
The smad binding protein 1 gene (SMADIP1, MIM 605802) has been recently identified as a disease causing gene in a polytopic embryonic defect (MIM 235730) including midline anomalies, facial dysmorphic features and enteric nervous system malformation (Hirschsprung disease). To confirm the pleiotropic role of SMADIP1 during embryogenesis and investigate its role in neural crest cell derivatives differentiation, we performed RNA in situ hybridization at early stages of human development. According to the spectrum of malformations observed in patients, expression of SMADIP1 is observed in neural crest derived cells (peripheric nervous system, enteric nervous system, facial neurectoderm and cranial nerve ganglia), central nervous system, genital tubercle, muscles and kidneys. Surprisingly, SMADIP1 expression is also found in limbs and developing eye. Although congenital heart defects are frequently observed in patients with either a SMADIP1 large scale deletion or truncating mutation, no SMADIP1 expression could be detected in the developing heart at the stages studied.
Collapse
Affiliation(s)
- Yolanda Espinosa-Parrilla
- Département de Génétique et Unité INSERM U-393, Hôpital Necker-Enfants Malades, 149, rue de Sèvres, 75743 Paris Cedex 15, France
| | | | | | | | | | | | | | | |
Collapse
|
212
|
|
213
|
Abstract
This review, which is presented in two parts, summarizes and synthesizes current views on the genetic, molecular, and cell biological underpinnings of the early embryonic phases of enteric nervous system (ENS) formation and its defects. In the first part, we describe the critical features of two principal abnormalities of ENS development: Hirschsprung's disease (HSCR) and intestinal neuronal dysplasia type B (INDB) in humans, and the similar abnormalities in animals. These represent the extremes of the diagnostic spectrum: HSCR has agreed and unequivocal diagnostic criteria, whereas the diagnosis and even existence of INDB as a clinical entity is highly controversial. The difficulties in diagnosis and treatment of both these conditions are discussed. We then review the genes now known which, when mutated or deleted, may cause defects of ENS development. Many of these genetic abnormalities in animal models give a phenotype similar or identical to HSCR, and were discovered by studies of humans and of mouse mutants with similar defects. The most important of these genes are those coding for molecules in the GDNF intercellular signaling system, and those coding for molecules in the ET-3 signaling system. However, a range of other genes for different signaling systems and for transcription factors also disturb ENS formation when they are deleted or mutated. In addition, a large proportion of HSCR cases have not been ascribed to the currently known genes, suggesting that additional genes for ENS development await discovery.
Collapse
Affiliation(s)
- Donald Newgreen
- Murdoch Children's Research Institute, Royal Children's Hospital, Parkville, 3052, Victoria, Australia
| | | |
Collapse
|
214
|
Fitze G, Cramer J, Ziegler A, Schierz M, Schreiber M, Kuhlisch E, Roesner D, Schackert HK. Association between c135G/A genotype and RET proto-oncogene germline mutations and phenotype of Hirschsprung's disease. Lancet 2002; 359:1200-5. [PMID: 11955539 DOI: 10.1016/s0140-6736(02)08218-1] [Citation(s) in RCA: 77] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/30/2022]
Abstract
BACKGROUND Several genes, including the major susceptibility gene RET, have roles in development of Hirschsprung's disease. Results of genetic-linkage analysis of patients with familial disease with both long-segment and short-segment phenotypes have shown close linkage with the RET locus. We aimed to investigate whether both RET mutations and polymorphisms contribute to phenotype of Hirschsprung's disease. METHODS We looked at the coding region of all 21 exons of the RET proto-oncogene, including the flanking intronic sequences, by direct DNA sequencing in 76 caucasians from Germany with Hirschsprung's disease. FINDINGS 20 different mutations were detected in 18 patients. Mutations were under-represented in patients with a homozygous RET c135A/A genotype in association with short-segment phenotype. Short-segment phenotype also arose if the RET mutation was on the c135A allele; conversely, a RET germline mutation on the c135G allele resulted in long-segment phenotype, particularly in heterozygous c135G/A patients. INTERPRETATION These observations lend support to the idea that both RET alleles have a role in pathogenesis of Hirschsprung's disease, in a dose-dependent fashion. We also showed that the c135G/A polymorphism modifies the phenotype by a within-gene interaction between the c135A variant and a mutation.
Collapse
Affiliation(s)
- Guido Fitze
- Department of Paediatric Surgery, University of Technology Dresden, Fetscherstrasse 74, D-01307 Dresden, Germany.
| | | | | | | | | | | | | | | |
Collapse
|
215
|
Borghini S, Bocciardi R, Bonardi G, Matera I, Santamaria G, Ravazzolo R, Ceccherini I. Hirschsprung associated GDNF mutations do not prevent RET activation. Eur J Hum Genet 2002; 10:183-7. [PMID: 11973622 DOI: 10.1038/sj.ejhg.5200785] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/15/2001] [Revised: 01/08/2002] [Accepted: 01/16/2002] [Indexed: 11/09/2022] Open
Abstract
Hirschsprung disease (HSCR) is a complex disorder characterised by aganglia of distal gastrointestinal tracts. The highest proportion of both familial and sporadic cases is due to mutations of the RET proto-oncogene. Five germline mutations in the glial cell-line-derived neurotrophic factor (GDNF) gene, one of the RET ligands, have been detected in HSCR patients. Pedigrees analysis and the observed association between these GDNF alterations and RET variants in the same patients raised the question of whether the GDNF gene plays any causative/predisposing role in HSCR pathogenesis. In the present work, we have studied the ability of GDNF proteins, each bearing one of the reported mutations, to activate RET by performing a functional test in cultured neuroblastoma cells. Consistently with the lack of genotype/phenotype correlation in human subjects, our results indicate absence of detectable alterations of mutant GDNF induced RET activation.
Collapse
Affiliation(s)
- Silvia Borghini
- Laboratorio di Genetica Molecolare, Istituto G. Gaslini, 16148 Genova, Italy
| | | | | | | | | | | | | |
Collapse
|
216
|
Zweier C, Albrecht B, Mitulla B, Behrens R, Beese M, Gillessen-Kaesbach G, Rott HD, Rauch A. ?Mowat-Wilson? syndrome with and without Hirschsprung disease is a distinct, recognizable multiple congenital anomalies-mental retardation syndrome caused by mutations in the zinc finger homeo box 1B gene. ACTA ACUST UNITED AC 2002. [DOI: 10.1002/ajmg.10226] [Citation(s) in RCA: 88] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
|
217
|
Papin C, van Grunsven LA, Verschueren K, Huylebroeck D, Smith JC. Dynamic regulation of Brachyury expression in the amphibian embryo by XSIP1. Mech Dev 2002; 111:37-46. [PMID: 11804777 DOI: 10.1016/s0925-4773(01)00599-8] [Citation(s) in RCA: 36] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
Abstract
Xenopus Brachyury (Xbra) plays a key role in mesoderm formation during early development. One factor thought to be involved in the regulation of Xbra is XSIP1, a zinc finger/homeodomain-like DNA-binding protein that belongs to the deltaEF1 family of transcriptional repressors. We show here that Xbra and XSIP1 are co-expressed at the onset of gastrulation, but that expression subsequently refines such that Xbra is expressed in prospective mesoderm and XSIP1 in anterior neurectoderm. This refinement of the expression patterns of the two genes is due in part to the ability of XSIP1 to repress expression of Xbra. This repression is highly specific, in the sense that XSIP1 does not repress the expression of other regionally expressed genes in the early embryo, and that other members of the family to which XSIP1 belongs, such as deltaEF1 and its Xenopus homologue ZEB, cannot regulate Xbra expression. The function of XSIP1 was studied further by making an interfering construct comprising the open reading frame of XSIP1 fused to the VP16 transactivation domain. Experiments using this chimeric protein suggest that XSIP1 is required for normal gastrulation movements to occur and for the development of the anterior neural plate.
Collapse
Affiliation(s)
- Catherine Papin
- Division of Developmental Biology, National Institute for Medical Research, The Ridgeway, Mill Hill, NW7 1AA, London, UK
| | | | | | | | | |
Collapse
|
218
|
Higashi Y, Maruhashi M, Nelles L, Van de Putte T, Verschueren K, Miyoshi T, Yoshimoto A, Kondoh H, Huylebroeck D. Generation of the floxed allele of the SIP1 (Smad-interacting protein 1) gene for Cre-mediated conditional knockout in the mouse. Genesis 2002; 32:82-4. [PMID: 11857784 DOI: 10.1002/gene.10048] [Citation(s) in RCA: 90] [Impact Index Per Article: 4.1] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Affiliation(s)
- Yujiro Higashi
- Laboratory of Developmental Biology, Institute for Molecular and Cellular Biology, Osaka University, Osaka, Japan.
| | | | | | | | | | | | | | | | | |
Collapse
|
219
|
Abstract
Hirschsprung disease is the most common congenital malformation of the enteric nervous system. Phenotypic expression is variable because of incomplete penetrance, and the pathogenesis is multifactorial. Although mutations of the RET tyrosine kinase gene remain the most commonly identified cause, there are now eight separate human gene loci identified whose mutations result in this disease. Analysis of these gene products in experimental animal models and cell systems has led to an increasing elucidation of the signaling pathways that are in operation during specific embryonic time stages and that direct the spatial arrangements and differentiation of enteric neuroblasts. Mutation analysis through in vitro cell expression studies has led to detailed descriptions of the affected microdomains of signal pathway receptors and the cellular pathogenesis of abnormal signaling that leads to apoptosis of developing neurons before the completion of enteric nervous system development. The full description of the pathogenesis of this disorder awaits the definition of new genetic loci, multiple gene interactions, and the acknowledgment of random events that may lead to aganglionosis of the distal bowel.
Collapse
Affiliation(s)
- William M Belknap
- Section of Pediatric Gastroenterology, Department of Pediatrics, Henry Ford Health System, Detroit, Michigan 48202, USA.
| |
Collapse
|
220
|
Yamada K, Yamada Y, Nomura N, Miura K, Wakako R, Hayakawa C, Matsumoto A, Kumagai T, Yoshimura I, Miyazaki S, Kato K, Sonta SI, Ono H, Yamanaka T, Nagaya M, Wakamatsu N. Nonsense and frameshift mutations in ZFHX1B, encoding Smad-interacting protein 1, cause a complex developmental disorder with a great variety of clinical features. Am J Hum Genet 2001; 69:1178-85. [PMID: 11592033 PMCID: PMC1235530 DOI: 10.1086/324343] [Citation(s) in RCA: 70] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/02/2001] [Accepted: 08/28/2001] [Indexed: 12/27/2022] Open
Abstract
Mutations in ZFHX1B, encoding Smad-interacting protein 1 (SIP1), have been recently reported to cause a form of Hirschsprung disease (HSCR). Patients with ZFHX1B deficiency typically show mental retardation, delayed motor development, epilepsy, microcephaly, distinct facial features, and/or congenital heart disease, in addition to the cardinal form of HSCR. To investigate the breadth of clinical variation, we studied DNA samples from six patients with clinical profiles quite similar to those described elsewhere for ZFHX1B deficiency, except that they did not have HSCR. The results showed the previously reported R695X mutation to be present in three cases, with three novel mutations-a 2-bp insertion (760insCA resulting in 254fs262X), a single-base deletion (270delG resulting in 91fs107X), and a 2-bp deletion (2178delTT resulting in 727fs754X)-newly identified in the other three. All mutations occurred in one allele and were de novo events. These results demonstrate that ZFHX1B deficiency is an autosomal dominant complex developmental disorder and that individuals with functional null mutations present with mental retardation, delayed motor development, epilepsy, and a wide spectrum of clinically heterogeneous features suggestive of neurocristopathies at the cephalic, cardiac, and vagal levels.
Collapse
Affiliation(s)
- Kenichiro Yamada
- Departments of Genetics and Biochemistry, Institute for Developmental Research; Departments of Pediatric Neurology, Psychiatry, Pediatrics, and Pediatric Surgery, Central Hospital; and Residental Facilities for Children with Mental and Physical Disabilities, Aichi Human Service Center, Kasugai, Japan
| | - Yasukazu Yamada
- Departments of Genetics and Biochemistry, Institute for Developmental Research; Departments of Pediatric Neurology, Psychiatry, Pediatrics, and Pediatric Surgery, Central Hospital; and Residental Facilities for Children with Mental and Physical Disabilities, Aichi Human Service Center, Kasugai, Japan
| | - Noriko Nomura
- Departments of Genetics and Biochemistry, Institute for Developmental Research; Departments of Pediatric Neurology, Psychiatry, Pediatrics, and Pediatric Surgery, Central Hospital; and Residental Facilities for Children with Mental and Physical Disabilities, Aichi Human Service Center, Kasugai, Japan
| | - Kiyokuni Miura
- Departments of Genetics and Biochemistry, Institute for Developmental Research; Departments of Pediatric Neurology, Psychiatry, Pediatrics, and Pediatric Surgery, Central Hospital; and Residental Facilities for Children with Mental and Physical Disabilities, Aichi Human Service Center, Kasugai, Japan
| | - Rie Wakako
- Departments of Genetics and Biochemistry, Institute for Developmental Research; Departments of Pediatric Neurology, Psychiatry, Pediatrics, and Pediatric Surgery, Central Hospital; and Residental Facilities for Children with Mental and Physical Disabilities, Aichi Human Service Center, Kasugai, Japan
| | - Chiemi Hayakawa
- Departments of Genetics and Biochemistry, Institute for Developmental Research; Departments of Pediatric Neurology, Psychiatry, Pediatrics, and Pediatric Surgery, Central Hospital; and Residental Facilities for Children with Mental and Physical Disabilities, Aichi Human Service Center, Kasugai, Japan
| | - Akiko Matsumoto
- Departments of Genetics and Biochemistry, Institute for Developmental Research; Departments of Pediatric Neurology, Psychiatry, Pediatrics, and Pediatric Surgery, Central Hospital; and Residental Facilities for Children with Mental and Physical Disabilities, Aichi Human Service Center, Kasugai, Japan
| | - Toshiyuki Kumagai
- Departments of Genetics and Biochemistry, Institute for Developmental Research; Departments of Pediatric Neurology, Psychiatry, Pediatrics, and Pediatric Surgery, Central Hospital; and Residental Facilities for Children with Mental and Physical Disabilities, Aichi Human Service Center, Kasugai, Japan
| | - Ikuko Yoshimura
- Departments of Genetics and Biochemistry, Institute for Developmental Research; Departments of Pediatric Neurology, Psychiatry, Pediatrics, and Pediatric Surgery, Central Hospital; and Residental Facilities for Children with Mental and Physical Disabilities, Aichi Human Service Center, Kasugai, Japan
| | - Shuji Miyazaki
- Departments of Genetics and Biochemistry, Institute for Developmental Research; Departments of Pediatric Neurology, Psychiatry, Pediatrics, and Pediatric Surgery, Central Hospital; and Residental Facilities for Children with Mental and Physical Disabilities, Aichi Human Service Center, Kasugai, Japan
| | - Kanefusa Kato
- Departments of Genetics and Biochemistry, Institute for Developmental Research; Departments of Pediatric Neurology, Psychiatry, Pediatrics, and Pediatric Surgery, Central Hospital; and Residental Facilities for Children with Mental and Physical Disabilities, Aichi Human Service Center, Kasugai, Japan
| | - Shin-ichi Sonta
- Departments of Genetics and Biochemistry, Institute for Developmental Research; Departments of Pediatric Neurology, Psychiatry, Pediatrics, and Pediatric Surgery, Central Hospital; and Residental Facilities for Children with Mental and Physical Disabilities, Aichi Human Service Center, Kasugai, Japan
| | - Hiroshi Ono
- Departments of Genetics and Biochemistry, Institute for Developmental Research; Departments of Pediatric Neurology, Psychiatry, Pediatrics, and Pediatric Surgery, Central Hospital; and Residental Facilities for Children with Mental and Physical Disabilities, Aichi Human Service Center, Kasugai, Japan
| | - Tsutomu Yamanaka
- Departments of Genetics and Biochemistry, Institute for Developmental Research; Departments of Pediatric Neurology, Psychiatry, Pediatrics, and Pediatric Surgery, Central Hospital; and Residental Facilities for Children with Mental and Physical Disabilities, Aichi Human Service Center, Kasugai, Japan
| | - Masahiro Nagaya
- Departments of Genetics and Biochemistry, Institute for Developmental Research; Departments of Pediatric Neurology, Psychiatry, Pediatrics, and Pediatric Surgery, Central Hospital; and Residental Facilities for Children with Mental and Physical Disabilities, Aichi Human Service Center, Kasugai, Japan
| | - Nobuaki Wakamatsu
- Departments of Genetics and Biochemistry, Institute for Developmental Research; Departments of Pediatric Neurology, Psychiatry, Pediatrics, and Pediatric Surgery, Central Hospital; and Residental Facilities for Children with Mental and Physical Disabilities, Aichi Human Service Center, Kasugai, Japan
| |
Collapse
|
221
|
Amiel J, Espinosa-Parrilla Y, Steffann J, Gosset P, Pelet A, Prieur M, Boute O, Choiset A, Lacombe D, Philip N, Le Merrer M, Tanaka H, Till M, Touraine R, Toutain A, Vekemans M, Munnich A, Lyonnet S. Large-scale deletions and SMADIP1 truncating mutations in syndromic Hirschsprung disease with involvement of midline structures. Am J Hum Genet 2001; 69:1370-7. [PMID: 11595972 PMCID: PMC1235547 DOI: 10.1086/324342] [Citation(s) in RCA: 79] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/13/2001] [Accepted: 08/28/2001] [Indexed: 11/03/2022] Open
Abstract
Hirschsprung disease (HSCR) is a common malformation of neural-crest-derived enteric neurons that is frequently associated with other congenital abnormalities. The SMADIP1 gene recently has been recognized as disease causing in some patients with 2q22 chromosomal rearrangement, resulting in syndromic HSCR with mental retardation, with microcephaly, and with facial dysmorphism. We screened 19 patients with HSCR and mental retardation and eventually identified large-scale SMADIP1 deletions or truncating mutations in 8 of 19 patients. These results allow further delineation of the spectrum of malformations ascribed to SMADIP1 haploinsufficiency, which includes frequent features such as hypospadias and agenesis of the corpus callosum. Thus, SMADIP1, which encodes a transcriptional corepressor of Smad target genes, may play a role not only in the patterning of neural-crest-derived cells and of CNS but also in the development of midline structures in humans.
Collapse
Affiliation(s)
- J Amiel
- Département de Génétique, et Unité INSERM U-393, Hôpital Necker-Enfants Malades, Paris, France
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
222
|
Abstract
Hirschsprung disease (HSCR, aganglionic megacolon) is the main genetic cause of functional intestinal obstruction with an incidence of 1/5000 live births. This developmental disorder is a neurocristopathy and is characterised by the absence of the enteric ganglia along a variable length of the intestine. In the last decades, the development of surgical approaches has dramatically decreased mortality and morbidity, which has allowed the emergence of familial cases. HSCR appeared to be a multifactorial malformation with low, sex dependent penetrance and variable expression according to the length of the aganglionic segment, suggesting the involvement of one or more gene(s) with low penetrance. So far, eight genes have been found to be involved in HSCR. This frequent congenital malformation now stands as a model for genetic disorders with complex patterns of inheritance.
Collapse
Affiliation(s)
- J Amiel
- Département de Génétique, Unité INSERM U-393, Hôpital Necker-Enfants Malades, 149 rue de Sèvres, 75743 Paris Cedex 15, France
| | | |
Collapse
|
223
|
Manié S, Santoro M, Fusco A, Billaud M. The RET receptor: function in development and dysfunction in congenital malformation. Trends Genet 2001; 17:580-9. [PMID: 11585664 DOI: 10.1016/s0168-9525(01)02420-9] [Citation(s) in RCA: 217] [Impact Index Per Article: 9.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/22/2022]
Abstract
Germline mutations in the RET proto-oncogene are responsible for two unrelated neural crest disorders: Hirschsprung disease, a congenital absence of the enteric nervous system in the hindgut, and multiple endocrine neoplasia type 2, a dominantly inherited cancer syndrome. Moreover, somatic rearrangements of RET are causally involved in the genesis of papillary thyroid carcinoma. The receptor tyrosine kinase encoded by the RET gene acts as the subunit of a multimolecular complex that binds four distinct ligands and activates a signalling network crucial for neural and kidney development. Over the past few years, a clearer picture of the mode of RET activation and of its multifaceted role during development has started to emerge. These findings, which provide new clues to the molecular mechanisms underlying RET signalling dysfunction in Hirschsprung disease, are summarized in this review.
Collapse
Affiliation(s)
- S Manié
- Laboratoire de Génétique, CNRS UMR 5641, Domaine Rockefeller, 8 avenue Rockefeller, 69373 Cedex 08, Lyon, France
| | | | | | | |
Collapse
|
224
|
Kääriäinen H, Wallgren-Pettersson C, Clarke A, Pihko H, Taskinen H, Rintala R. Hirschsprung disease, mental retardation and dysmorphic facial features in five unrelated children. Clin Dysmorphol 2001; 10:157-63. [PMID: 11446406 DOI: 10.1097/00019605-200107000-00001] [Citation(s) in RCA: 21] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Abstract
We report five patients with Hirschsprung disease, severe mental retardation and dysmorphic facial features including hypertelorism, prominent forehead and dysmorphic ears. All four boys had hypospadias. All had postnatally retarded growth. One of them had a de novo apparently balanced translocation 46,XY,t(2;11)(q22.2;q21). There are several reports on patients with Hirschsprung disease, mental retardation and various dysmorphic features. Some of them, especially those reported by Tanaka et al. [(1993) Pediatr Neurol 9:479-481], Lurie et al. [(1994) Genet Couns 5:11-14] and Mowat et al. [(1998) J Med Genet 35:617-623] closely resemble our patients suggesting that they have the same malformation syndrome.
Collapse
Affiliation(s)
- H Kääriäinen
- Department of Medical Genetics, The Family Federation of Finland, Helsinki.
| | | | | | | | | | | |
Collapse
|
225
|
Comijn J, Berx G, Vermassen P, Verschueren K, van Grunsven L, Bruyneel E, Mareel M, Huylebroeck D, van Roy F. The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion. Mol Cell 2001; 7:1267-78. [PMID: 11430829 DOI: 10.1016/s1097-2765(01)00260-x] [Citation(s) in RCA: 1037] [Impact Index Per Article: 45.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/16/2022]
Abstract
Transcriptional downregulation of E-cadherin appears to be an important event in the progression of various epithelial tumors. SIP1 (ZEB-2) is a Smad-interacting, multi-zinc finger protein that shows specific DNA binding activity. Here, we report that expression of wild-type but not of mutated SIP1 downregulates mammalian E-cadherin transcription via binding to both conserved E2 boxes of the minimal E-cadherin promoter. SIP1 and Snail bind to partly overlapping promoter sequences and showed similar silencing effects. SIP1 can be induced by TGF-beta treatment and shows high expression in several E-cadherin-negative human carcinoma cell lines. Conditional expression of SIP1 in E-cadherin-positive MDCK cells abrogates E-cadherin-mediated intercellular adhesion and simultaneously induces invasion. SIP1 therefore appears to be a promoter of invasion in malignant epithelial tumors.
Collapse
Affiliation(s)
- J Comijn
- Molecular Cell Biology Unit, Department of Molecular Biology, VIB-Ghent University, B-9000, Ghent, Belgium
| | | | | | | | | | | | | | | | | |
Collapse
|
226
|
Tumoración ovárica gigante de crecimiento retroperitoneal. CLINICA E INVESTIGACION EN GINECOLOGIA Y OBSTETRICIA 2001. [DOI: 10.1016/s0210-573x(01)77129-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
|